Another genetic recombinant approach fused Gel with the anti-insulin-like growth factor-1 receptor (IGF-1R), a 58 amino acid long peptide that can specifically bind to receptors, overexpressed in cancer cells [64]. This evidence concerns the gene IGF1R and cancer.